Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zhendong Chen"'
Autor:
Weijian Guo, Rubing Han, Zhendong Chen, Nong Xu, Lei Yang, Shubin Wang, Haijun Zhong, Donghui Chen, Rui-Hua Xu, Wei Li, Ning Wang, Ying Yuan, Shukui Qin, Songhua Fan, Xiaojun Guo, Peiguo Cao, Yongqian Shu, Zhuang Yu, Jianfeng Zhou, Bin Zhang, Hongbing Wang, Dong Ma, Lin Shen, Hongming Pan, Ying Cheng, Sanyuan Sun, Changping Wu, Jianming Xu, Yuxian Bai, Haihui Chen, Yanhong Deng, Jin Li, Tianshu Liu
Publikováno v:
Advances in Therapy. 37:4585-4598
In FRESCO (Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients) trial, fruquintinib demonstrated a statistically significant and clinically meaningful overall survival benefit in Chinese patients with metastatic colorectal cancer (
Autor:
Yuqin Song, Hui Zhou, Huilai Zhang, Wei Liu, Yuerong Shuang, Keshu Zhou, Fangfang Lv, Hao Xu, Jianfeng Zhou, Wei Li, Huaqing Wang, Hongyu Zhang, Haiwen Huang, Qingyuan Zhang, Wei Xu, Zheng Ge, Ying Xiang, Shuye Wang, Da Gao, Shun’e Yang, Jinying Lin, Lin Wang, Liqun Zou, Meifang Zheng, Jing Liu, Zonghong Shao, Ying Pang, Ruixiang Xia, Zhendong Chen, Ming Hou, Hongxia Yao, Ru Feng, Zhen Cai, Mingzhi Zhang, Wenhua Ran, Lin Liu, Shan Zeng, Wei Yang, Peng Liu, Aibin Liang, Xuelan Zuo, Qingfeng Zou, Junxun Ma, Wei Sang, Ye Guo, Wei Zhang, Yongqing Cao, Yan Li, Jifeng Feng, Xin Du, Xiaohong Zhang, Hongguo Zhao, Jie Yu, Xing Sun, Jun Zhu, Lugui Qiu
Publikováno v:
Advances in therapy. 38(4)
Patients with diffuse large B-cell lymphoma (DLBCL) have limited access to rituximab. IBI301 is a recombinant chimeric murine/human anti-CD20 monoclonal antibody and is a candidate biosimilar to rituximab. This study aimed to assess the therapeutic e